Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease

  • Heidi I.L. Jacobs
  • , John Alex Becker
  • , Kenneth Kwong
  • , Diana Munera
  • , Liliana Ramirez-Gomez
  • , Nina Engels-Domínguez
  • , Justin S. Sanchez
  • , Clara Vila-Castelar
  • , Ana Baena
  • , Reisa A. Sperling
  • , Keith A. Johnson
  • , Francisco Lopera
  • , Yakeel T. Quiroz

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Autopsy studies recognize the locus coeruleus (LC) as one of the first sites accumulating tau in Alzheimer's disease (AD). Recent AD work related in vivo LC magnetic resonance imaging (MRI) integrity to tau and cognitive decline; however, relationships of LC integrity to age, tau, and cognition in autosomal dominant AD (ADAD) remain unexplored. Methods: We associated LC integrity (3T-MRI) with estimated years of onset, cortical amyloid beta, regional tau (positron emission tomography [PET]) and memory (Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word-List-Learning) among 27 carriers and 27 non-carriers of the presenilin-1 (PSEN1) E280A mutation. Longitudinal changes between LC integrity and tau were evaluated in 10 carriers. Results: LC integrity started to decline at age 32 in carriers, 12 years before clinical onset, and 20 years earlier than in sporadic AD. LC integrity was negatively associated with cortical tau, independent of amyloid beta, and predicted precuneus tau increases. LC integrity was positively associated with memory. Discussion: These findings support LC integrity as marker of disease progression in preclinical ADAD.

Original languageEnglish
Pages (from-to)169-180
Number of pages12
JournalAlzheimer's and Dementia
Volume19
Issue number1
DOIs
StatePublished - Jan 2023

Keywords

  • Alzheimer's disease
  • autosomal dominant
  • brainstem
  • early onset
  • locus coeruleus
  • tau

Fingerprint

Dive into the research topics of 'Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease'. Together they form a unique fingerprint.

Cite this